Integrated Clinical Systems, Inc. Opens European Branch Office in Switzerland
Integrated Clinical Systems, Inc. announced the opening of a European branch office in Switzerland
Integrated Clinical Systems, Inc. (ICS) www.i-review.com, developers of Integrated Review™ & JReview®, the world’s most comprehensive clinical review and analysis software tool, today announced the opening of a European branch office in Switzerland. The office will be the company’s first location in Europe, dedicated to client management and business development in Europe, Middle East & Africa (EMEA).
ICS’s EMEA branch office is located in Lausanne, Switzerland. It will be led by Dr. Mark Demesmaeker, Director of EMEA & Asia Operations, who joined the company in January from TIBCO Spotfire where he headed the clinical analytics practice.
Eric S. Herbel, President of ICS said, “Our European customers have been frequently asking for an ICS regional presence and support. As a consequence, we have decided to set up a European branch office in order to better serve our European customers and also expand our footprint in the EMEA region.”
“About 40% of our customer base is located in Europe and the business is constantly growing” says Dr. Demesmaeker. “Many of our clients are global corporations with regional headquarters. Expanding and scaling a high-quality customer service and business development team is a key driver to our continued success in the market.”
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
